Scopus BioPharma Cash from Financing (TTM) Analysis

Scopus BioPharma Inc (SCPS)

0.0011 0.00 (0.00%) USD | OTCM | May 17, 14:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
June 30, 2023	2.217M
March 31, 2023	2.261M
December 31, 2022	0.2419M
September 30, 2022	8.480M
June 30, 2022	8.376M
March 31, 2022	8.356M
December 31, 2021	17.56M
September 30, 2021	11.44M
June 30, 2021	11.87M

Date	Value
March 31, 2021	13.47M
December 31, 2020	4.353M
September 30, 2020	1.989M
June 30, 2020	2.049M
March 31, 2020	1.430M
December 31, 2019	2.184M
September 30, 2019	2.186M
June 30, 2019	1.977M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.2419M

Minimum

Dec 2022

17.56M

Maximum

Dec 2021

5.908M

Average

2.261M

Median

Mar 2023

Cash from Financing (TTM) Benchmarks